You are here

lung cancer

Personalized Blood Test Detecting ctDNA Can Help Predict Lung Cancer Relapse

Xtalks

Wed, 04/6/22 - 12:06 pm

BioNTech and Regeneron expand their cancer partnership, pushing new Libtayo combo into NSCLC

Endpoints

Tue, 03/8/22 - 10:41 am

AstraZeneca faces $278M Imfinzi patent infringement lawsuit from co-developer Ono

Fierce Pharma

Tue, 03/1/22 - 10:32 am

Ono Pharmaceutical

American Lung Association campaign, backed by pharma, tackles lack of diversity in lung cancer trials

Fierce Pharma

Fri, 02/11/22 - 10:31 am

pharma marketing

American Lung Association

FDA sends signal with tough questions of Lilly at cancer drug meeting

BioPharma Dive

Thu, 02/10/22 - 10:37 pm

Innovent Biologics

clinical trials

Amgen hold-up gives Mirati a vital lifeline

EP Vantage

Thu, 02/10/22 - 10:12 am

Mirati Therapeutics

clinical trials

FDA gives Daiichi Sankyo’s HER3 drug a breakthrough tag

Pharmaforum

Thu, 12/23/21 - 11:53 am

antibody-drug conjugate

patritumab deruxtecan

Startup Mythic Therapeutics emerges with $103M to control fate of ADC cancer drugs

MedCity News

Thu, 12/16/21 - 12:02 pm

Mythic Therapeutics

antibody-drug conjugate

Roche builds case for TIGIT combo in untreated lung cancer

Pharmaforum

Fri, 12/10/21 - 10:50 am

Bristol Myers adds to neoadjuvant win for Opdivo in lung cancer, escalating early cancer showdown with Merck

Endpoints

Mon, 11/8/21 - 10:58 am

Bristol Myers Squibb

Takeda launches value-based pricing program for lung cancer med Alunbrig, promises more deals to come

Fierce Pharma

Mon, 11/8/21 - 10:54 am

value-based pricing

Novartis hits another setback in plan to repurpose rare disease drug in lung cancer

BioPharma Dive

Mon, 10/25/21 - 11:51 pm

clinical trials

Calithera buys itself a plan B

EP Vantage

Tue, 10/19/21 - 10:43 am

Calithera Biosciences

B cell lymphoma

Bayer teams up with Huma to apply AI to lung cancer diagnosis

Pharmaforum

Wed, 09/29/21 - 11:57 pm

artificial intelligence

AstraZeneca touts Imfinzi immunotherapy combos for lung cancer in push to drive PD-L1 drug uptake

Endpoints

Fri, 09/17/21 - 10:58 am

Takeda gets a win for its Wave1 pipeline, as Exkivity nabs FDA approval

Pharmaforum

Thu, 09/16/21 - 10:44 am

World Lung 2021 – front-line competition lines up behind Keytruda

EP Vantage

Tue, 09/14/21 - 10:43 am

CStone Pharmaceuticals

Shanghai Junshi Biosciences

Could CureVac's Canceled Deal Spell Trouble for Other mRNA Cancer Vaccines?

Motley Fool

Fri, 08/27/21 - 10:54 am

Boehringer Ingelheim

Moderna Therapeutics

J&J lung cancer initiative will use Optellum’s ‘digital biomarker’ tech

Pharmaforum

Thu, 08/26/21 - 08:42 pm

digital biomarker

artificial intelligence

Regeneron drug extends survival in lung cancer trial, lifting company's hopes in field

BioPharma Dive

Thu, 08/5/21 - 11:02 pm

clinical trials

Pages